Nasdaq
PPCB
Propanc Biopharma, Inc.
- Health Care
- Australia
- 1 day
- +15.3%
- 1 month
- −25.3%
- 1 year
- —
$1.36 · Mkt cap $4.76M
At the 6 Aug 2026 close
Nasdaq
Propanc Biopharma, Inc.
$1.36 · Mkt cap $4.76M
At the 6 Aug 2026 close
Propanc Biopharma, Inc. trades under the ticker PPCB on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its market capitalisation is $4.76M. The last closing price was $1.36, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing.
This page exists because PPCB is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.